Anti-inflammatory effects of monoammonium glycyrrhizinate on lipopolysaccharide-induced acute lung injury in mice through regulating nuclear factor-kappa b signaling pathway

Evidence-based Complementary and Alternative Medicine

Volumn 2015, Issue , 2015, Pages

  Huang, Xiaoying ^a   Tang, Jiangfeng ^a   Cai, Hui ^a   Pan, Yi ^b   He, Yicheng ^a   Dai, Caijun ^a   Chen, Ali ^a   Yu, Xiaoming ^a   Chen, Mayun ^a   Zou, Lizhen ^a   Wang, Liangxing ^a  

^a THE FIRST AFFILIATED HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

^b Respiratory Department Changxing Traditional Chinese Medicine Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIUM DERIVATIVE; ANTIINFLAMMATORY AGENT; GLYCYRRHIZIC ACID DERIVATIVE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MONOAMMONIUM GLYCYRRHIZINATE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL INFILTRATION; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRY WEIGHT; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOPATHOLOGY; INFLAMMATORY CELL; LUNG ALVEOLUS WALL; LUNG EDEMA; LUNG HEMORRHAGE; LUNG HOMOGENATE; LUNG LAVAGE; LUNG WEIGHT; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; THERAPY EFFECT; WESTERN BLOTTING;

EID: 84926318255     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2015/272474     Document Type: Article

References (39)

1. A. Piper, Y. Song, N. D. Eves, and T. M. Maher, "Year in review 2013: acute lung injury, interstitial lung diseases, sleep and physiology" Respirology, vol. 19, no. 3, pp. 428-437, 2014.
2. M.-H. Ji, X.-L. Zhu, F.-F. Liu et al., "Alpha 2A-adrenoreceptor blockade improves sepsis-induced acute lung injury accompanied with depressed high mobility group box-1 levels in rats" Cytokine, vol. 60, no. 3, pp. 639-645, 2012.
3. G. D. Rubenfeld, E. Caldwell, E. Peabody et al., "Incidence and outcomes of acute lung injury" The New England Journal of Medicine, vol. 353, no. 16, pp. 1685-1693, 2005.
4. M. A. Matthay, L. B. Ware, and G. A. Zimmerman, "The acute respiratory distress syndrome" The Journal of Clinical Investigation, vol. 122, no. 8, pp. 2731-2740, 2012.
5. A. Savva and T. Roger, "Targeting toll-like receptors: promising therapeutic strategies for the management of sepsis-associated pathology and infectious diseases" Frontiers in Immunology, vol. 4, p. 387, 2013.
6. B. Wang, X. Gong, J. Y. Wan et al., "Resolvin D1 protectsmice from LPS-induced acute lung injury" Pulmonary Pharmacology an d Therapeutics, vol. 24, no. 4, pp. 434-441, 2011.
7. H. Chen, C. Bai, and X. Wang, "The value of the lipopolysaccharide-induced acute lung injury model in respiratory medicine" Expert Review of Respiratory Medicine, vol. 4, no. 6, pp. 773-783, 2010.
8. G. Wang, X. Huang, Y. Li, K. Guo, P. Ning, and Y. Zhang, "PARP-1 inhibitor, DPQ, attenuates LPS-induced acute lung injury through inhibiting NF-κB-mediated inflammatory response" PLoS ONE, vol. 8, no. 11, Article ID e79757, 2013.
9. S. Takeda, K. Ishihara, Y. Wakui et al., "Bioavailability study of glycyrrhetic acid after oral administration of glycyrrhizin in rats; relevance to the intestinal bacterial hydrolysis" Journal of Pharmacy and Pharmacology, vol. 48, no. 9, pp. 902-905, 1996.
10. M. N. Asl and H. Hosseinzadeh, "Review of pharmacological effects of Glycyrrhiza sp. and its bioactive compounds" Phytotherapy Research, vol. 22, no. 6, pp. 709-724, 2008.
11. T. C. Kao, M. H. Shyu, and G. C. Yen, "Glycyrrhizic acid and 18β-glycyrrhetinic acid inhibit inflammation via PI3K/Akt/GSK3β signaling and glucocorticoid receptor activation" Journal of Agricultural and FoodChemistry, vol. 58, no. 15, pp. 8623-8629, 2010.
12. Z. Yu, Y. Ohtaki, K. Kai et al., "Critical roles of platelets in lipopolysaccharide-induced lethality: effects of glycyrrhizin and possible strategy for acute respiratory distress syndrome" International Immunopharmacology, vol. 5, no. 3, pp. 571-580, 2005.
13. H.-F. Tang, L.-G. Mao, R.-A. Jiang, Y. Qian, and J.-Q. Chen, "Protective effect against monoammonium glycyrrhizinate on lipopolysaccharide-induced acute lung injury in mice" Acta Pharmaceutica Sinica, vol. 42, no. 9, pp. 954-958, 2007.
14. J. Gong, Z.-Y. Wu, H. Qi et al., "Maresin1mitigates LPS-induced acute lung injury in mice" British Journal of Pharmacology, vol. 171, no. 14, pp. 3539-3550, 2014.
15. K. Suda, M. Tsuruta, J. Eom et al., "Acute lung injury induces cardiovascular dysfunction: effects of IL-6 and budesonide/formoterol" American Journal of Respiratory Cell and Molecular Biology, vol. 45, no. 3, pp. 510-516, 2011.
16. Y. Sun, T.-T. Cai, Y. Shen, X.-B. Zhou, T. Chen, and Q. Xu, "Si-Ni-San, a traditional Chinese prescription, and its active ingredient glycyrrhizin ameliorate experimental colitis through regulating cytokine balance" International Immunopharmacology, vol. 9, no. 12, pp. 1437-1443, 2009.
17. Y. F. Ni, J. K. Kuai, Z. F. Lu et al., "Glycyrrhizin treatment is associated with attenuation of lipopolysaccharide-induced acute lung injury by inhibiting cyclooxygenase-2 and inducible nitric oxide synthase expression" Journal of Surgical Research, vol. 165, no. 1, pp. e29-e35, 2011.
18. M. Menegazzi, R. Di Paola, E. Mazzon et al., "Glycyrrhizin attenuates the development of carrageenan-induced lung injury in mice" Pharmacological Research, vol. 58, no. 1, pp. 22-31, 2008.
19. H. C. Müller-Redetzky, N. Suttorp, and M. Witzenrath, "Dynamics of pulmonary endothelial barrier function in acute inflammation: mechanisms and therapeutic perspectives" Cell and Tissue Research, vol. 355, no. 3, pp. 657-673, 2014.
20. J. J. Grailer, M. Kalbitz, F. S. Zetoune, and P. A. Ward, "Persistent neutrophil dysfunction and suppression of acute lung injury in mice following cecal ligation and puncture sepsis" Journal of Innate Immunity, vol. 6, no. 5, pp. 695-705, 2014.
21. J. Grommes and O. Soehnlein, "Contribution of neutrophils to acute lung injury" Molecular Medicine, vol. 17, no. 3-4, pp. 293-307, 2011.
22. H.-Y. Yao, L.-H. Zhang, J. Shen et al., "Cyptoporus polysaccharide prevents lipopolysaccharide-induced acute lung injury associated with down-regulating Toll-like receptor 2 expression" Journal of Ethnopharmacology, vol. 137, no. 3, pp. 1267-1274, 2011.
23. P.-K. Fu, C.-L. Wu, T.-H. Tsai, and C.-L. Hsieh, "Antiinflammatory and anticoagulative effects of paeonol on LPSinduced acute lung injury in rats" Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 837513, 12 pages, 2012.
24. T. Yoshikawa, H. Takano, S. Takahashi, H. Ichikawa, and M. Kondo, "Changes in tissue antioxidant enzyme activities and lipid peroxides in endotoxin-induced multiple organ failure" Circulatory Shock, vol. 42, no. 1, pp. 53-58, 1994.
25. I. A. J. Giebelen, D. J. van Westerloo, G. J. LaRosa, A. F. de Vos, and T. van der Poll, "Local stimulation of α7 cholinergic receptors inhibits LPS-induced TNF-α release in the mouse lung" Shock, vol. 28, no. 6, pp. 700-703, 2007.
26. C. D. Yeo, C. K. Rhee, I. K. Kim et al., "Protective effectofpravastatin on lipopolysaccharide-induced acute lung injury during neutropenia recovery in mice" Experimental Lung Research, vol. 39, no. 2, pp. 99-106, 2013.
27. M. K. McCoy, K. A. Ruhn, A. Blesch, and M. G. Tansey, "TNF: a key neuroinflammatory mediator of neurotoxicity and neurodegeneration in models of Parkinsons disease" Advances in Experimental Medicine and Biology, vol. 691, pp. 539-540, 2011.
28. M. Bhatia and S. Moochhala, "Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome" The Journal of Pathology, vol. 202, no. 2, pp. 145-156, 2004.
29. L. Arbibe, D. Vial, I. Rosinski-Chupin et al., "Endotoxin induces expression of type II phospholipase A2 inmacrophagees during acute lung injury in guinea pigs: involvement of TNF-alpha in lipopolysaccharide-induced type II phospholipase A2 synthesis" The Journal of Immunology, vol. 159, no. 1, pp. 391-400, 1997.
30. G. Chi, M. Wei, X. Xie, L. W. Soromou, F. Liu, and S. Zhao, "Suppression ofMAPK and NF-κB pathways by limonene contributes to attenuation of lipopolysaccharide-induced inflammatory responses in acute lung injury" Inflammation, vol. 36, no. 2, pp. 501-511, 2013.
31. H. Li, Z. Wu, D. Feng et al., "BML-111, a lipoxin receptor agonist, attenuates ventilator-induced lung injury in rats" Shock, vol. 41, no. 4, pp. 311-316, 2014.
32. T. Zhu, D.-X. Wang, W. Zhang et al., "Andrographolide protects against LPS-induced acute lung injury by inactivation of NF-κB" PLoS ONE, vol. 8, no. 2, Article ID e56407, 2013.
33. T. Lawrence and C. Fong, "The resolution of inflammation: anti-inflammatory roles for NF-κB" The International Journal of Biochemistry and Cell Biology, vol. 42, no. 4, pp. 519-523, 2010.
34. D. Liang, Y. Sun, Y. Shen et al., "Shikonin exerts antiinflammatory effects in a murine model of lipopolysaccharideinduced acute lung injury by inhibiting the nuclear factorkappaB signaling pathway" International Immunopharmacology, vol. 16, no. 4, pp. 475-480, 2013.
35. P.-J. Yu, J.-R. Li, Z.-G. Zhu et al., "Praeruptorin D and E attenuate lipopolysaccharide/hydrochloric acid induced acute lung injury in mice" European Journal of Pharmacology, vol. 710, no. 1-3, pp. 39-48, 2013.
36. H. Wang, L. Xu, J. Zhao et al., "Regulatorymechanism of pyrrolidine dithiocarbamate is mediated by nuclear factor-κB and inhibits neutrophil accumulation in ARDS mice" Experimental andTherapeutic Medicine, vol. 8, no. 2, pp. 614-622, 2014.
37. A. C. Ledoux and N. D. Perkins, "NF-κB and the cell cycle" Biochemical Society Transactions, vol. 42, no. 1, pp. 76-81, 2014.
38. R. G. Baker, M. S. Hayden, and S. Ghosh, "NF-kappa B, inflammation, and metabolic disease" Cell Metabolism, vol. 13, no. 1, pp. 11-22, 2011.
39. J. Zou and F. Crews, "Induction of innate immune gene expression cascades in brain slice cultures by ethanol: key role of nf-κb and proinflammatory cytokines" Alcoholism: Clinical and Experimental Research, vol. 34, no. 5, pp. 777-789, 2010.